Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Sep 5, 2021 (Letter of inquiry)

Later deadlines: Oct 5, 2021 (Full proposal), Nov 5, 2021 (Full proposal)

Grant amount: Up to US $2,000,000

Fields of work: Bioengineering Cancer/Oncology

Applicant type: Organizations

Funding uses: Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE:

  • Applications are due by 5 p.m. submitter's local time. 
  • Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.

The Cancer TEC Program will:

  • Catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research,
  • Expand the breadth of these systems to several cancer types, and
  • Promote the exploration of cancer phenomena with biomimetic tissue-engineered systems.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities

This page was last reviewed December 19, 2018 and last updated December 19, 2018